Feed Preview

Fast Growing

Statin Medications & Heart Disease

Statin Medications & Heart Disease diagram by Jatlas2

Statins or HMG-CoA reductase inhibitors, are used clinically to lower cholesterol levels and have been associated with decreased risk of heart disease. Discover the latest research on Statin Medications & Heart Disease here.

Top 20 most recent papers

Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial

CirculationNovember 11, 2019
Amy DamaskRegeneron Genetics Center and the ODYSSEY OUTCOMES Investigators
Circulation. Cardiovascular Quality and Outcomes

Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial

Circulation. Cardiovascular Quality and OutcomesNovember 1, 2019
Jonathan D NewmanDavid J Maron
Journal of the American College of Cardiology

Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome

Journal of the American College of CardiologyOctober 19, 2019
Kuan Ken LeeHigh-STEACS investigators
Cardiovascular Diabetology

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

Cardiovascular DiabetologyNovember 9, 2019
Kausik Kumar RayLawrence A Leiter
JAMA Cardiology

Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial

JAMA CardiologyNovember 13, 2019
Alexander C FanaroffTracy Y Wang
Scientific Reports

Statin Short-term Inhibition of Insulin Sensitivity and Secretion During Acute Phase of ST-Elevation Myocardial Infarction

Scientific ReportsNovember 8, 2019
Andrei Carvalho SpositoJose Carlos Quinaglia E Silva
Mayo Clinic Proceedings

Sea Change for Marine Omega-3s: Randomized Trials Show Fish Oil Reduces Cardiovascular Events

Mayo Clinic ProceedingsOctober 15, 2019
Evan L O'KeefeJames H O'Keefe

MitoPlex: A Targeted Multiple Reaction Monitoring Assay for Quantification of a Curated Set of Mitochondrial Proteins

bioRxivOctober 25, 2019
Aleksandr StotlandSarah J Parker

Low total cholesterol is associated with increased major adverse cardiovascular events in men aged ≥70 years not taking statins

HeartOctober 13, 2019
Sonali Rukshana GnanenthiranFiona M Blyth
Circulation. Cardiovascular Quality and Outcomes

Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program

Circulation. Cardiovascular Quality and OutcomesNovember 1, 2019
Joe X XieKreton Mavromatis
BMC Medicine

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups

BMC MedicineNovember 4, 2019
Georg GelbeneggerJolanta Maria Siller-Matula
Thrombosis Research

Initiation of statins and risk of venous thromboembolism: Population-based matched cohort study

Thrombosis ResearchNovember 6, 2019
Nils SkajaaHenrik Toft Sørensen

Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review

AtherosclerosisSeptember 24, 2019
Giancarlo AgnelliUlrich Hoffmann
Journal of Atherosclerosis and Thrombosis

Network Medicine: A Clinical Approach for Precision Medicine and Personalized Therapy in Coronary Heart Disease

Journal of Atherosclerosis and ThrombosisNovember 12, 2019
Teresa InfanteClaudio Napoli
Journal of the American Heart Association

Association Between Neighborhood Walkability and Predicted 10-Year Cardiovascular Disease Risk: The CANHEART (Cardiovascular Health in Ambulatory Care Research Team) Cohort

Journal of the American Heart AssociationNovember 1, 2019
Nicholas A HowellGillian L Booth
Annals of Pediatric Endocrinology & Metabolism

Association of metformin and statin medications with surrogate measures of cardiovascular disease in youth with type 1 diabetes: the SEARCH for diabetes in youth study

Annals of Pediatric Endocrinology & MetabolismSeptember 1, 2019
Evgenia GourgariDana M Dabelea
Annals of Vascular Surgery

Association of Plasma Marker of Oxidized Lipid with Histologic Plaque Instability in Patients with Peripheral Artery Disease

Annals of Vascular SurgeryNovember 7, 2019
Kichun KimDong-Ju Choi
BMJ Open

Exploring the role of hospitals and office-based physicians in timely provision of statins following acute myocardial infarction: a secondary analysis of a nationwide cohort using cross-classified multilevel models

BMJ OpenOctober 16, 2019
Laura SchangLeonie Sundmacher
The American Journal of Cardiology

Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes

The American Journal of CardiologySeptember 26, 2019
Ahmed AlTurkiThao K Huynh
Journal of the American Board of Family Medicine : JABFM

Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal

Journal of the American Board of Family Medicine : JABFMNovember 11, 2019
Quyen Ngo-MetzgerArlene S Bierman

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2019 Meta ULC. All rights reserved